合成路线1
该中间体在本合成路线中的序号:
(III) The reaction of 4-chloro-1-(4-fluorophenyl)-1-butanone (I) with ethylene glycol and p-toluenesulfonic acid in refluxing benzene gives the corresponding ethyleneketal (II), which is condensed with 4-hydroxypiperidine (III) by means of K2CO3 in hot DMF yielding 1-(4-fluorophenyl)-4-(4-hydroxypiperidin-1-yl)-1-butanone ethyleneketal (IV). The Oppenauer oxidation of (IV) with 9-fluorenone and potassium tert-butoxide in hot benzene affords the piperidinone (V), which is condensed with 4-bromo-N-(trimethylsilyl)aniline (VI) by means of BuLi in hot hexane to give 4-[4-(4-aminophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)-1-butanone (VII). Finally, this compound is treated with CuBr2 and NO in THF.
【1】
Vincent, S.H.; et al.; Synthesis of [82Br]bromperidol and preliminary tissue distribution studies in the rat. J Med Chem 1980, 23, 1, 75.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11295 |
Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol |
107-21-1 |
C2H6O2 |
详情 | 详情
|
(I) |
35864 |
4-chloro-1-(4-fluorophenyl)-1-butanone
|
3874-54-2 |
C10H10ClFO |
详情 | 详情
|
(II) |
28203 |
2-(3-chloropropyl)-2-(4-fluorophenyl)-1,3-dioxolane
|
3308-94-9 |
C12H14ClFO2 |
详情 | 详情
|
(III) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(IV) |
35865 |
1-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]-4-piperidinol
|
|
C17H24FNO3 |
详情 |
详情
|
(V) |
35866 |
1-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]-4-piperidinone
|
|
C17H22FNO3 |
详情 |
详情
|
(VI) |
35867 |
N-(4-bromophenyl)(trimethyl)silanamine; N-(4-bromophenyl)-N-(trimethylsilyl)amine
|
|
C9H14BrNSi |
详情 |
详情
|
(VII) |
35868 |
4-[4-(4-aminophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone
|
|
C21H25FN2O2 |
详情 |
详情
|
(VIII) |
22531 |
4-Bromoaniline; 4-Bromophenylamine
|
106-40-1 |
C6H6BrN |
详情 | 详情
|
(IX) |
35869 |
|
|
C6H5Br2MgN |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(III) The reaction of 4-chloro-1-(4-fluorophenyl)-1-butanone (I) with ethylene glycol and p-toluenesulfonic acid in refluxing benzene gives the corresponding ethylene-ketal (II), which is condensed with 4-hydroxypiperidine (III) by means of K2CO3 in hot DMF yielding 1-(4-fluorophenyl)-4-(4-hydroxypiperidin-1-yl)-1-butanone ethyle-neketal (IV). The Oppenauer oxidation of (IV) with 9-fluorenone and potassium tert-butoxide in hot benzene affords the piperidinone (V), which is condensed with 4-bromo-N-(trimethylsilyl)aniline (VI) by means of BuLi in hot hexane to give 4-[4-(4-aminophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)-1-butanone (VII). Finally, this compound is treated with Cu82Br2 and NO in THF.
【1】
Vincent, S.H.; et al.; Synthesis of [82Br]bromperidol and preliminary tissue distribution studies in the rat. J Med Chem 1980, 23, 1, 75.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11295 |
Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol |
107-21-1 |
C2H6O2 |
详情 | 详情
|
(I) |
35864 |
4-chloro-1-(4-fluorophenyl)-1-butanone
|
3874-54-2 |
C10H10ClFO |
详情 | 详情
|
(II) |
28203 |
2-(3-chloropropyl)-2-(4-fluorophenyl)-1,3-dioxolane
|
3308-94-9 |
C12H14ClFO2 |
详情 | 详情
|
(III) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(IV) |
35865 |
1-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]-4-piperidinol
|
|
C17H24FNO3 |
详情 |
详情
|
(V) |
35866 |
1-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]-4-piperidinone
|
|
C17H22FNO3 |
详情 |
详情
|
(VI) |
35867 |
N-(4-bromophenyl)(trimethyl)silanamine; N-(4-bromophenyl)-N-(trimethylsilyl)amine
|
|
C9H14BrNSi |
详情 |
详情
|
(VII) |
35868 |
4-[4-(4-aminophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone
|
|
C21H25FN2O2 |
详情 |
详情
|
(VIII) |
22531 |
4-Bromoaniline; 4-Bromophenylamine
|
106-40-1 |
C6H6BrN |
详情 | 详情
|
(IX) |
35869 |
|
|
C6H5Br2MgN |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) 3-(4-Hydroxypiperidino)-6-(2-chlorophenyl)pyridazine (CM-40907) is synthesized from 3-chloro-6-(2-chlorophenyl)pyridazine (I) in boiling 1-butanol (A) with an excess of 4-hydroxypiperidine (II).
【1】
Chambon, J.P.; Brodin, R.; Biziere, K.; Hallot, A.; Roncucci, R.; Brochard, J.; Heaulme, M.; CM 40907: A structurally novel anticonvulsant in mice, rats and baboons. J Pharmacol Exp Ther 1985, 233, 3, 836-844.
|
【2】
Loscher, W.; CM-40907. Drugs Fut 1985, 10, 11, 903.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
29766 |
butanol; n-butanol; 1-butanol
|
71-36-3 |
C4H10O |
详情 | 详情
|
(I) |
29765 |
3-chloro-6-(2-chlorophenyl)pyridazine
|
|
C10H6Cl2N2 |
详情 |
详情
|
(II) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(II) The reaction of 3-chloro-6-(2,4-dicliorophenyl)-pyridazine (I) with 4 hydroxypiperidine (I) in refluxing n-butano and heating gives 6-(2,4-dichlorophenyl)-3-(4 hydroxypiperidino)pyridazine.
【1】
Dubois, M.; SR-41378. Drugs Fut 1986, 11, 4, 286.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24032 |
3-Chloro-6-(2,4-dichlorophenyl)pyridazine
|
|
C10H5Cl3N2 |
详情 |
详情
|
(II) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
The bromination of 5-fluoro-2-methylquinoline (I) with Br2 and Ag2SO4 in H2SO4 or with Br2 and AlCl3 gives 5-bromo-6-fluoro-2-methylquinoline (II), which is reduced with H2 over PtO2 in acetic acid, yielding 5-bromo-6-fluoro-2-methyl-1,2,3,4-tetrahydroquinoline (III). The cyclization of (III) with diethyl ethoxymethylenemalonate (IV) and polyphosphoric acid (PPA) at 150 C affords 8-bromo-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid (V), which is finally condensed with 4-hydroxypiperidine (VI) by heating at 160 C in HMPT.
【1】
Kano, M.; Nakagawa, K.; Ishikawa, H.; Uno, T. (Otsuka Pharmaceutical Co., Ltd.); Antibacterial agents. JP 1983090511 .
|
【2】
Bernauer, K.; Borgulya, J.; Bruderer, H.; Da Prada, M.; Zurcher, G. (F. Hoffmann-La Roche AG); 3,5-Disubstituted pyrocatechol derivs. EP 0237929; US 5389653; US 5476875 .
|
【3】
Ishikawa, H.; Tabusa, F.; Miyamoto, H.; Kano, M.; Ueda, H.; Tamaoka, H.; Nakagawa, K.; Synthesis of substituted 6,7-dihydro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acids. Chem Pharm Bull 1989, 37, 8, 2103-8.
|
【4】
Prous, J.; Castaner, J.; OPC-7251. Drugs Fut 1990, 15, 7, 685.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(I) |
10869 |
6-Fluoro-2-methylquinoline
|
1128-61-6 |
C10H8FN |
详情 | 详情
|
(II) |
10870 |
5-Bromo-6-fluoro-2-methylquinoline
|
|
C10H7BrFN |
详情 |
详情
|
(III) |
10871 |
5-Bromo-6-fluoro-2-methyl-1,2,3,4-tetrahydroquinoline
|
|
C10H11BrFN |
详情 |
详情
|
(IV) |
10872 |
diethyl 2-[(E)-ethoxymethylidene]succinate
|
|
C11H18O5 |
详情 |
详情
|
(V) |
10873 |
8-Bromo-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid
|
|
C14H11BrFNO3 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(V) Synthesis of intermediate (X):
4-Hydroxypiperidine (V) is protected with ethyl chloroformate to give (VI), which is then condensed with bromodiphenylmethane in the presence of sodium carbonate yielding (VII). AIkali hydrolysis of (VII) gives (VIII), which is then treated with N-(2-bromoethyl)phthalimide to yield (IX). (IX) is then deprotected by a treatment of 80% hydrazine hydrate, producing (X).
【1】
Tasaka, K.; TMK-688. Drugs Fut 1988, 13, 12, 1056.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
37025 |
2-(2-bromoethyl)-1H-isoindole-1,3(2H)-dione
|
574-98-1 |
C10H8BrNO2 |
详情 | 详情
|
(IIb) |
12079 |
Bromodiphenylmethane; 1-[Bromo(phenyl)methyl]benzene; Benzhydrylbromide
|
776-74-9 |
C13H11Br |
详情 | 详情
|
(V) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(VI) |
22709 |
ethyl 4-hydroxy-1-piperidinecarboxylate
|
|
C8H15NO3 |
详情 |
详情
|
(VII) |
12080 |
ethyl 4-(benzhydryloxy)tetrahydro-1(2H)-pyridinecarboxylate
|
|
C21H25NO3 |
详情 |
详情
|
(VIII) |
12081 |
4-(Benzhydryloxy)piperidine; Benzhydryl 4-piperidinyl ether
|
|
C18H21NO |
详情 |
详情
|
(IX) |
22713 |
2-[2-[4-(benzhydryloxy)-1-piperidinyl]ethyl]-1H-isoindole-1,3(2H)-dione
|
|
C28H28N2O3 |
详情 |
详情
|
(X) |
22707 |
2-[4-(benzhydryloxy)-1-piperidinyl]ethylamine; 2-[4-(benzhydryloxy)-1-piperidinyl]-1-ethanamine
|
|
C20H26N2O |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) This compound can be obtained by two related routes:
1) Condensation of 4-hydroxypiperidine (I) with p-tert-butyl-omega-chlorobutyrophenone (II) in hot methyl isobutyl ketone in presence of sodium bicarbonate gives 1-[3-(4-tert-butylbenzoyl)propyl]-4-hydroxypiperidine (III), which reacts with diphenylmethyl bromide (IV) in methyl isobutyl ketone to give ebastine.
2) 4-Diphenylmethoxypiperidine (VI), obtained by alkaline hydrolysis of 1-ethoxycarbonyl-4-diphenyl-methoxypiperidine (V) was reacted with p-tert-butyl-omega-chlorobutyrophenone (II) to give ebastine.
【1】
Spickett, R.G.W.; Moragues, J.; Prieto, J.; Vega, A. (Fordonal S.A.); Piperidine derivs. EP 0134124B; US 4550116 .
|
【2】
Moragues, J.; Roberts, D.J.; EBASTINE. Drugs Fut 1990, 15, 7, 674.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(II) |
12077 |
4-Chloro-1-[4-(1,1-dimethylethyl)phenyl]-1-butanone; 1-[4-(tert-Butyl)phenyl]-4-chloro-1-butanone; 4'-tert-Butyl-4-chlorobutyrophenone
|
43076-61-5 |
C14H19ClO |
详情 | 详情
|
(III) |
12078 |
1-[4-(tert-Butyl)phenyl]-4-(4-hydroxypiperidino)-1-butanone
|
|
C19H29NO2 |
详情 |
详情
|
(IV) |
12079 |
Bromodiphenylmethane; 1-[Bromo(phenyl)methyl]benzene; Benzhydrylbromide
|
776-74-9 |
C13H11Br |
详情 | 详情
|
(V) |
12080 |
ethyl 4-(benzhydryloxy)tetrahydro-1(2H)-pyridinecarboxylate
|
|
C21H25NO3 |
详情 |
详情
|
(VI) |
12081 |
4-(Benzhydryloxy)piperidine; Benzhydryl 4-piperidinyl ether
|
|
C18H21NO |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(VI) The racemic form of E-5880 is prepared as follows:
The esterification of 2-methoxy-1,3-propanediol (I) with phenyl chlorocarbonate (II) in pyridine gives the diester (III), which is treated with 2-(aminomethyl)pyridine (IV) in refluxing chloroform, yielding the carbamate (V). The reaction of (V) with 4-hydroxypiperidine (VI) in refluxing chloroform affords the dicarbamate (VII), which by treatment with octadecyl isocyanate (VIII) gives the tricarbamate (X). Alternatively, (X) can be obtained by treatment of (VIII) with carbonate (II), yielding the intermediate (IX), which by treatment with octadecylamine (XI) at 100 C affords (X). The acylation of (X) with 2-methoxybenzoyl chloride (XII) in pyridine gives the precursor (XIII), which is finally treated with ethyl iodide in excess at reflux temperature and submitted to an ion exchange resin (Amberlite IRA-410 Cl- type).
The optically active (R)-enantiomer is synthesized starting from L-mannitol.
【1】
Okano, K.; Asano, O.; Shimomura, N.; Kawahara, T.; Abe, S.; Miyazawa, S.; Miyamoto, M.; Yoshimura, H.; Harada, K.; Nagaoka, J.; Kawata, T.; Yoshimura, T.; Suzuki, H.; Souda, S.; Machida, Y.; Katayama, K.; Yamatsu, I. (Eisai Co., Ltd.); Glycerin deriv. and its pharmacological use. AU 8937213; EP 0353474; JP 1990131467; JP 1996231508; US 5037827; US 5273985; US 5476863; US 5476864 . |
【2】
Okano, K.; Shimomura, N.; Asano, O.; et al.; Okano, K., Asano, O., Shimomura, N. et al. Structure-activity relationships of platelet activating factor (PAF) antagonists. 198th ACS Natl Meet (Sept 10-15, Miami Beach) 1989, Abst MEDI 55.
|
【3】
Prous, J.; Castaner, J.; E-5880. Drugs Fut 1992, 17, 12, 1082.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13579 |
2-Methoxy-1,3-propanediol
|
|
C4H10O3 |
详情 |
详情
|
(II) |
13580 |
1-[(Chlorocarbonyl)oxy]benzene; phenyl chloroformate
|
1885-14-9 |
C7H5ClO2 |
详情 | 详情
|
(III) |
13581 |
2-methoxy-3-[(phenoxycarbonyl)oxy]propyl phenyl carbonate
|
|
C18H18O7 |
详情 |
详情
|
(IV) |
13582 |
2-Pyridinylmethanamine; 2-Pyridinylmethylamine; 2-(Aminomethyl)pyridine
|
3731-51-9 |
C6H8N2 |
详情 | 详情
|
(V) |
13583 |
(5-oxo-6-phenyl-1,4-dioxan-2-yl)methyl 2-pyridinylmethylcarbamate
|
|
C18H18N2O5 |
详情 |
详情
|
(VI) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(VII) |
13585 |
2-methoxy-3-([[(2-pyridinylmethyl)amino]carbonyl]oxy)propyl 4-hydroxy-1-piperidinecarboxylate
|
|
C17H25N3O6 |
详情 |
详情
|
(VIII) |
13586 |
1-Isocyanatooctadecane; octadecyl isocyanate
|
112-96-9 |
C19H37NO |
详情 | 详情
|
(IX) |
13587 |
2-methoxy-3-([[(2-pyridinylmethyl)amino]carbonyl]oxy)propyl 4-[(phenoxycarbonyl)oxy]-1-piperidinecarboxylate
|
|
C24H29N3O8 |
详情 |
详情
|
(X) |
13588 |
2-methoxy-3-([[(2-pyridinylmethyl)amino]carbonyl]oxy)propyl 4-[[(octadecylamino)carbonyl]oxy]-1-piperidinecarboxylate
|
|
C36H62N4O7 |
详情 |
详情
|
(XI) |
13589 |
1-Aminooctadecane; Octadecylamine; 1-Octadecanamine
|
124-30-1 |
C18H39N |
详情 | 详情
|
(XII) |
13590 |
2-Methoxybenzoyl chloride; o-Anisoyl chloride; 2-Anisoyl chloride
|
21615-34-9 |
C8H7ClO2 |
详情 | 详情
|
(XIII) |
13591 |
2-methoxy-3-([[(2-methoxybenzoyl)(2-pyridinylmethyl)amino]carbonyl]oxy)propyl 4-[[(octadecylamino)carbonyl]oxy]-1-piperidinecarboxylate
|
|
C44H68N4O9 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(IV) Reaction of theophylline (I) with 1,3-dibromopropane (II) in DMF in the presence of triethylamine afforded the bromo intermediate (III)) in 77% yield. Reaction of (III) with 4-hydroxypiperidine (IV) in DMF in the presence of sodium bicarbonate afforded the unsubstituted hydroxypiperidinyl intermediate (V) in 31% yield which was subsequently alkylated with diphenylmethylbromide (VI) to afford Wy-49,051 in 29% yield.
【1】
Abou-Gharbia, M.A.; Nielsen, S.T.; Webb, M.B. (American Home Products Corp.); Histamine H1-antagonists. EP 0271192; GB 2196963; JP 1988152381; US 4716166 .
|
【2】
Abou-Gharbia, M.; Wy-49,051. Drugs Fut 1990, 15, 2, 137.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
63786 |
1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
|
|
C7H8N4O2 |
详情 |
详情
|
(II) |
12581 |
1,3-Dibromopropane
|
109-64-8 |
C3H6Br2 |
详情 | 详情
|
(III) |
13592 |
7-(3-Bromopropyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
|
|
C10H13BrN4O2 |
详情 |
详情
|
(IV) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(V) |
13593 |
7-[3-(4-Hydroxy-1-piperidinyl)propyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
|
|
C15H23N5O3 |
详情 |
详情
|
(VI) |
12079 |
Bromodiphenylmethane; 1-[Bromo(phenyl)methyl]benzene; Benzhydrylbromide
|
776-74-9 |
C13H11Br |
详情 | 详情
|
(VII) |
63787 |
7-{3-[4-(benzhydryloxy)-1-piperidinyl]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
|
|
C28H33N5O3 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(I) The acylation of 4-hydroxypiperidine (I) with benzyl chloroformate (II) by means of triethylamine in dichloromethane gives 4-hydroxypiperidine-1-carboxylic acid benzyl ester (III), which is condensed with tert-butyl bromoacetate (IV) by means of tetrabutylammonium hydrogensulfate and NaOH in toluene/water, affording 2-[1-(benzyloxycarbonyl)piperidin-4-yloxy]acetic acid tert-butyl ester (V). The deprotection of (V) by hydrogenation with H2 over Pd/C in ethanol gives the piperidine (VI), which is condensed with N-(benzyloxycarbonyl)-4-O-tert-butyl-L-tyrosine (VII) by means of 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) and N-methylmorpholine (NMM) in dichloromethane, yielding the expected condensation product (VIII). The deprotection of the amino group of (VIII) by hydrogenation as before affords (IX), which is N-acylated with 4-amidinobenzoyl chloride (X), prepared by reaction of 4-amidinobenzoic acid (XI) with SOCl2, giving the bis-tert-butylated product (XII). Finally, this compound is deprotected by means of trifluoroacetic acid in dichloromethane.
【1】
Weller, T.; Hadvary, P.; Trzeciak, A.; Knopp, D.; Steiner, B.; Edenhofer, A.; Muller, M.; Hurzeler, M.; Alig, L.; Low molecular weight, non-peptide fibrinogen receptor antagonists. J Med Chem 1992, 35, 23, 4393.
|
【2】
Castaner, J.; Merlos, M.; Cases, A.; Rabasseda, X.; Lamifiban. Drugs Fut 1999, 24, 3, 261.
|
【3】
Alig, L.; Hadvary, P.; Huzeler, M.; Muller, M.; Steiner, B.; Weller, T. (F. Hoffmann-La Roche AG); N-acyl-alpha-aminoacids derivs.. EP 0505868; JP 1993148204; US 5378712; US 5545658; US 5658928; US 5670515; US 5747522 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(II) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(III) |
19284 |
benzyl 4-hydroxy-1-piperidinecarboxylate
|
|
C13H17NO3 |
详情 |
详情
|
(IV) |
17430 |
2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate
|
5292-43-3 |
C6H11BrO2 |
详情 | 详情
|
(V) |
19286 |
benzyl 4-[2-(tert-butoxy)-2-oxoethoxy]-1-piperidinecarboxylate
|
|
C19H27NO5 |
详情 |
详情
|
(VI) |
19287 |
tert-butyl 2-(4-piperidinyloxy)acetate
|
|
C11H21NO3 |
详情 |
详情
|
(VII) |
22478 |
(2S)-2-[[(benzyloxy)carbonyl]amino]-3-[4-(tert-butoxy)phenyl]propionic acid
|
|
C21H25NO5 |
详情 |
详情
|
(VIII) |
22479 |
tert-butyl 2-[(1-[(2S)-2-[[(benzyloxy)carbonyl]amino]-3-[4-(tert-butoxy)phenyl]propanoyl]-4-piperidinyl)oxy]acetate
|
|
C32H44N2O7 |
详情 |
详情
|
(IX) |
22480 |
tert-butyl 2-[(1-[(2S)-2-amino-3-[4-(tert-butoxy)phenyl]propanoyl]-4-piperidinyl)oxy]acetate
|
|
C24H38N2O5 |
详情 |
详情
|
(X) |
22481 |
4-[amino(imino)methyl]benzoyl chloride
|
|
C8H7ClN2O |
详情 |
详情
|
(XI) |
22482 |
4-Amidinobenzic acid; 4-[amino(imino)methyl]benzoic acid
|
15535-95-2 |
C8H8N2O2 |
详情 | 详情
|
(XII) |
22483 |
tert-butyl 2-[(1-[(2S)-2-([4-[amino(imino)methyl]benzoyl]amino)-3-[4-(tert-butoxy)phenyl]propanoyl]-4-piperidinyl)oxy]acetate
|
|
C32H44N4O6 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
The key intermediate (VI) is synthesized through the condensation of 5-methylnicotinic acid (VIII) with 4-hydroxypiperidine by means of DCC in DMF to give amide (IX), followed by reduction with POCl3 and NaBH4 to give the amino alcohol (X), which is treated with SOCl2.
【1】
Carceller, E.; Jiménez, P.J.; Salas, J. (J. Uriach & Cia., SA); Process for the preparation of 8-chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridinyl)methyl]-4-piperidinylidene]-5H-benzo[5,6]cyclohepta[1,2-b]pyridine. ES 9602107 . |
【2】
García-Rafanell, J.; Rupatadine Fumarate. Drugs Fut 1996, 21, 10, 1032. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(VI) |
16505 |
4-chloro-1-[(5-methyl-3-pyridinyl)methyl]piperidine
|
|
C12H17ClN2 |
详情 |
详情
|
(VIII) |
16507 |
5-methylnicotinic acid
|
3222-49-9 |
C7H7NO2 |
详情 | 详情
|
(IX) |
16508 |
(4-hydroxypiperidino)(5-methyl-3-pyridinyl)methanone
|
|
C12H16N2O2 |
详情 |
详情
|
(X) |
16509 |
1-[(5-methyl-3-pyridinyl)methyl]-4-piperidinol
|
|
C12H18N2O |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(VII) 2) The reaction of 4-hydroxypiperidine (VII) with benzyl chloroformate (VIII) by means of triethylamine in dichloromethane gives the expected benzyloxycarbonyl derivative (IX), which is condensed with tert-butyl 2-bromoacetate (X) by means of tetrabutylammonium bisulfate and NaOH, yielding 2-[1-(benzyloxycarbonyl)piperidin-4-yloxy]acetic acid tert-butyl ester (XI). The deprotection of (XI) as ususal affords 2-(4-piperidinyloxy)acetic acid tert-butyl ester (XII), which is condensed with N-(benzyloxycarbonyl)-L-alanine (XIII) by means of 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) and N-methyl-morpholine (NMM) in dichloromethane to yield the acylated piperidine (XIV). The deprotection of (XIV) as usual affords compound (XV), which is acylated at the free amino group with 4-cyanobenzoyl chloride (V) and tetrabutylammonium bisulfate to give 2-[1-[N-(4-cyanobenzoyl)-L-alanyl]piperidin-4-yloxy]acetic acid tert-butyl ester (XVI). The reaction of the cyano group of (XVI) with hydroxylamine affords compound (XVII) with a hydroxyamidino substituent. Finally, the tert-butyl ester group of (XVII) is converted in ethyl ester by hydrolysis with hot fomic acid to the corresponding acetic acid (XVIII) and subsequent esterification with ethanol/H2SO4.
【1】
Alig, L.; Beresini, M.; Weller, T.; et al.; Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines. J Med Chem 1996, 39, 16, 3139.
|
【2】
Weller, T.; Hadvary, P.; Trzeciak, A.; Knopp, D.; Steiner, B.; Edenhofer, A.; Muller, M.; Hurzeler, M.; Alig, L.; Low molecular weight, non-peptide fibrinogen receptor antagonists. J Med Chem 1992, 35, 23, 4393.
|
【3】
Castañer, J.; Graul, A.; Merlos, M.; Sibrafiban . Drugs Fut 1998, 23, 12, 1297.
|
【4】
Alig, L.; Hadvary, P.; Hurzeler Muller, M.; Muller, M.; Steiner, B.; Weller, T. (F. Hoffmann-La Roche AG); Acetic acid derivs. as medicaments. EP 0656348; JP 1995196592; US 5726185 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
19280 |
4-cyanobenzoyl chloride
|
6068-72-0 |
C8H4ClNO |
详情 | 详情
|
(VII) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(VIII) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(IX) |
19284 |
benzyl 4-hydroxy-1-piperidinecarboxylate
|
|
C13H17NO3 |
详情 |
详情
|
(X) |
17430 |
2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate
|
5292-43-3 |
C6H11BrO2 |
详情 | 详情
|
(XI) |
19286 |
benzyl 4-[2-(tert-butoxy)-2-oxoethoxy]-1-piperidinecarboxylate
|
|
C19H27NO5 |
详情 |
详情
|
(XII) |
19287 |
tert-butyl 2-(4-piperidinyloxy)acetate
|
|
C11H21NO3 |
详情 |
详情
|
(XIII) |
61209 |
CBZ-L-Alanine; (2S)-2-[[(Benzyloxy)carbonyl]amino]propionic acid; N-((Phenylmethoxy)carbonyl)-alanine; Carbobenzyloxy-L-alanine
|
|
C11H13NO4 |
详情 |
详情
|
(XIV) |
19289 |
tert-butyl 2-[[1-((2S)-2-[[(benzyloxy)carbonyl]amino]propanoyl)-4-piperidinyl]oxy]acetate
|
|
C22H32N2O6 |
详情 |
详情
|
(XV) |
19290 |
tert-butyl 2-([1-[(2S)-2-aminopropanoyl]-4-piperidinyl]oxy)acetate
|
|
C14H26N2O4 |
详情 |
详情
|
(XVI) |
19291 |
tert-butyl 2-[(1-[(2S)-2-[(4-cyanobenzoyl)amino]propanoyl]-4-piperidinyl)oxy]acetate
|
|
C22H29N3O5 |
详情 |
详情
|
(XVII) |
19292 |
tert-butyl 2-([1-[(2S)-2-([4-[amino(hydroxyimino)methyl]benzoyl]amino)propanoyl]-4-piperidinyl]oxy)acetate
|
|
C22H32N4O6 |
详情 |
详情
|
(XVIII) |
19293 |
2-([1-[(2S)-2-([4-[amino(hydroxyimino)methyl]benzoyl]amino)propanoyl]-4-piperidinyl]oxy)acetic acid
|
|
C18H24N4O6 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(II) The reaction of N-(tert-butoxycarbonyl)-L-4-fluorophenylalanine (I) with 4-hydroxypiperidine (II) by means of triethylamine, EDC and HOBT in dichloromethane gives the expected piperidide (III), which is deprotected with with HCl in dioxane to afford (IV) with a free amino group that is condensed with 5-chloro-1H-indole-2-carboxylic acid (V) by means of triethylamine, EDC and HOBT as before.
【1】
Hoover, D.J.; et al.; Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase. J Med Chem 1998, 41, 16, 2934.
|
【2】
Hulin, B.; Hoover, D.J.; Treadway, J.L.; Martin, W.H.; Phillips, D. (Pfizer Inc.); Substd. N-(indole-2-carbonyl)-glycinamides and derivs. as glycogen phosphorylase inhibitors. EP 0832065; WO 9639384 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25929 |
(2S)-2-[(tert-butoxycarbonyl)amino]-3-(4-fluorophenyl)propionic acid
|
|
C14H18FNO4 |
详情 |
详情
|
(II) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(III) |
25930 |
tert-butyl (1S)-1-(4-fluorobenzyl)-2-(4-hydroxy-1-piperidinyl)-2-oxoethylcarbamate
|
|
C19H27FN2O4 |
详情 |
详情
|
(IV) |
25931 |
(2S)-2-amino-3-(4-fluorophenyl)-1-(4-hydroxy-1-piperidinyl)-1-propanone
|
|
C14H19FN2O2 |
详情 |
详情
|
(V) |
25932 |
5-Chloroindole-2-carboxylic acid; 5-Chloro-1H-indole-2-carboxylic acid
|
10517-21-2 |
C9H6ClNO2 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(IX) 5-Bromovaleryl chloride (VI) was reduced to aldehyde (VII) by means of lithium tri-tert-butoxyaluminumhydride at -78 C and subsequently converted into the dimethyl acetal (VIII) with H2SO4 in methanol (1). Alkylation of 4-hydroxypiperidine (IX) with bromoacetal (VIII) gave adduct (X). This was subjected to Fisher indolization with the hydrazine (V), yielding indole (XI). The piperidine hydroxyl group was then oxidized to the corresponding ketone (XII) using sulfur trioxide-pyridine complex in DMSO.
【1】
Matassa, V.G.; Pengilley, R.R.; Russell, M.G.N.; et al.; 3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT1D receptor agonists. J Med Chem 1999, 42, 24, 4981.
|
【2】
Baker, R.; Bourrain, S.; Castro Pineiro, J.L.; Chambers, M.S.; Guiblin, A.R.; Hobbs, S.C.; Jelley, R.A.; Madin, A.; Matassa, V.G.; Reeve, A.J.; Russell, M.G.N.; Showell, G.A.; Sternfeld, F.; Street, L.J.; Van Niel, M.B. (Merck Sharp & Dohme Ltd.); Azetidine, pyrrolidine and piperidine derivs.. EP 0804434; JP 1998503768; US 5854268; WO 9604274 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
25647 |
4-(4-hydrazinophenyl)-4H-1,2,4-triazole
|
|
C8H9N5 |
详情 |
详情
|
(VI) |
39700 |
5-bromopentanoyl chloride
|
4509-90-4 |
C5H8BrClO |
详情 | 详情
|
(VII) |
43094 |
5-bromopentanal
|
|
C5H9BrO |
详情 |
详情
|
(VIII) |
25645 |
5-bromo-1-methoxypentyl methyl ether; 5-bromo-1,1-dimethoxypentane
|
|
C7H15BrO2 |
详情 |
详情
|
(IX) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(X) |
43095 |
1-(5,5-dimethoxypentyl)-4-piperidinol
|
|
C12H25NO3 |
详情 |
详情
|
(XI) |
43096 |
1-[3-[5-(4H-1,2,4-triazol-4-yl)-1H-indol-3-yl]propyl]-4-piperidinol
|
|
C18H23N5O |
详情 |
详情
|
(XII) |
43097 |
1-[3-[5-(4H-1,2,4-triazol-4-yl)-1H-indol-3-yl]propyl]-4-piperidinone
|
|
C18H21N5O |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(VII) The reaction of 4-aminophthalimide (I) with NaNO2/HCl and then with CuCl/KCN gives 4-cyanophthalimide (II), which is treated with hydrazone in ethanol, yielding 6-cyanophthalazine-2,3(1H,4H)-dione (III). The reaction of (III) with refluxing POCl3 affords 1,4-dichlorophthalazine-6-carbonitrile (IV), which is condensed with 3-chloro-4-methoxybenzylamine (V) by means of TEA in THF to provide the secondary amine (VI). Finally, this compound is condensed with 4-hydroxypiperidine (VII) by means of DIEA in N-methyl-2-pyrrolidone to furnish the target phthalazine.
【1】
Watanabe, N.; Kabasawa, Y.; Takase, Y.; Ozaki, F.; Ishibashi, K.; Miyazaki, K.; Matsukura, M.; Souda, S.; Miyake, K.; Ishihara, H.; Kodama, K.; Adachi, H. (Eisai Co., Ltd.); Fused pyridazine cpd.. EP 0722936; JP 1996225541; US 6218392; WO 9605176 .
|
【2】
Takase, Y.; Adachi, H.; Watanabe, N.; et al.; 4-(3-Chloro-4-methoxybenzyl)aminophthalazines: Synthesis and inhibitory activity toward phosphodiesterase 5. J Med Chem 2000, 43, 13, 2523.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51974 |
5-amino-1H-isoindole-1,3(2H)-dione
|
|
C8H6N2O2 |
详情 |
详情
|
(II) |
51975 |
1,3-dioxo-5-isoindolinecarbonitrile
|
|
C9H4N2O2 |
详情 |
详情
|
(III) |
51976 |
1,4-dioxo-1,2,3,4-tetrahydro-6-phthalazinecarbonitrile
|
|
C9H5N3O2 |
详情 |
详情
|
(IV) |
51977 |
1,4-dichloro-6-phthalazinecarbonitrile
|
|
C9H3Cl2N3 |
详情 |
详情
|
(V) |
51978 |
(3-chloro-4-methoxyphenyl)methanamine; 3-chloro-4-methoxybenzylamine
|
|
C8H10ClNO |
详情 |
详情
|
(VI) |
51979 |
1-chloro-4-[(3-chloro-4-methoxybenzyl)amino]-6-phthalazinecarbonitrile
|
|
C17H12Cl2N4O |
详情 |
详情
|
(VII) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(II) The condensation of the commercially available (Amersham) 14C-labeled 1-chloro-4-(3-chloro-4-methoxybenzylamino)phthalazine-6-carbonitrile (I) with 4-hydroxypiperidine (II) by means of K2CO3 and N-methyl-2-pyrrolidinone at 170 C yields the target phthalazine derivative.
【1】
Watanabe, N.; et al.; Synthesis of 14C-labeled E4010. J Label Compd Radiopharm 2001, 44, 12, 843.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51979 |
1-chloro-4-[(3-chloro-4-methoxybenzyl)amino]-6-phthalazinecarbonitrile
|
|
C17H12Cl2N4O |
详情 |
详情
|
(I) |
51980 |
1-chloro-4-[(3-chloro-4-methoxybenzyl)amino]-6-phthalazinecarbonitrile
|
|
C17H12Cl2N4O |
详情 |
详情
|
(II) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(I) 4-Hydroxypiperidine (I) was protected as the tert-butyl carbamate (II) upon treatment with (Boc)2O. Subsequent Mitsunobu coupling of (II) with diphenyl disulfide using tributylphosphine and diethyl azodicarboxylate afforded thioether (III). Acid deprotection of the Boc group of (III), followed by nitrosation of the resulting amine (IV) gave N-nitrosopiperidine (V). Further reduction of (V) with LiAlH4 yielded hydrazine (VI). Condensation of (VI) with dichloropurine derivative (VII) produced piperidinyladenosine (VIII). Debenzoylation of the tribenzoate ester (VIII) with methanolic ammonia gave (IX). Then, chlorination at position 5' with concomitant formation of the 2',3' cyclic sulfite (X) by reaction with thionyl chloride and pyridine was followed by sulfite hydrolysis with methanolic ammonia to yield the title compound.
【1】
Lau, J.; Judge, M.E.; Sheardown, M.J.; Petersen, H.; Shalmi, M.; Knutsen, L.J.S.; Hansen, A.J.; Thomsen, C.; Weis, J.U.; N-substituted adenosines as novel neuroprotective A1 agonists with diminished hypotensive effects. J Med Chem 1999, 42, 18, 3463. |
【2】
Lau, J.; Knutsen, L.J.S. (Novo Nordisk A/S); Chemical cpds., their preparation and use. EP 0719275; JP 1999511436; US 5589467; WO 9507921 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
17473 |
diphenyl disulfide; 1-(phenyldisulfanyl)benzene; diphenyldisulfide
|
882-33-7 |
C12H10S2 |
详情 | 详情
|
(I) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(II) |
18625 |
tert-butyl 4-hydroxy-1-piperidinecarboxylate
|
|
C10H19NO3 |
详情 |
详情
|
(III) |
32561 |
tert-butyl 4-(phenylsulfanyl)-1-piperidinecarboxylate
|
|
C16H23NO2S |
详情 |
详情
|
(IV) |
32562 |
4-(phenylsulfanyl)piperidine; phenyl 4-piperidinyl sulfide
|
|
C11H15NS |
详情 |
详情
|
(V) |
32563 |
1-nitroso-4-piperidinyl phenyl sulfide; 1-nitroso-4-(phenylsulfanyl)piperidine
|
|
C11H14N2OS |
详情 |
详情
|
(VI) |
32564 |
4-(phenylsulfanyl)-1-piperidinamine; 4-(phenylsulfanyl)-1-piperidinylamine
|
|
C11H16N2S |
详情 |
详情
|
(VII) |
32565 |
(2R,3R,4R,5R)-4-(benzoyloxy)-2-[(benzoyloxy)methyl]-5-(2,6-dichloro-9H-purin-9-yl)tetrahydro-3-furanyl benzoate
|
|
C31H22Cl2N4O7 |
详情 |
详情
|
(VIII) |
32568 |
[(2R,3R,4R,5R)-3,4-bis(benzoyloxy)-5-(2-chloro-6-[[4-(phenylsulfanyl)-1-piperidinyl]amino]-9H-purin-9-yl)tetrahydro-2-furanyl]methyl benzoate
|
|
C42H37ClN6O7S |
详情 |
详情
|
(IX) |
32566 |
(2R,3R,4S,5R)-2-(2-chloro-6-[[4-(phenylsulfanyl)-1-piperidinyl]amino]-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydro-3,4-furandiol
|
|
C21H25ClN6O4S |
详情 |
详情
|
(X) |
32567 |
(3aR,4S,6R,6aR)-4-(chloromethyl)-6-(2-chloro-6-[[4-(phenylsulfanyl)-1-piperidinyl]amino]-9H-purin-9-yl)tetrahydro-2lambda(4)-furo[3,4-d][1,3,2]dioxathiol-2-one
|
|
C21H22Cl2N6O4S2 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(I) Condensation of 4-hydroxypiperidine (I) with methyl 3,4-difluorobenzoate (II) in DMSO yields derivative (III), which is first mesylated with methanesulfonyl chloride (MsCl) and Et3N in CH2Cl2 and then subjected to reaction with NaN3 in DMF to provide azido derivative (IV). Hydrogenation of (IV) over Pd/C in HOAc/H2O/dioxane affords amino derivative (V), which is then condensed with 2-bromopyrimidine (VI) in DMSO in the presence of DIEA, yielding derivative (VII). Methyl ester group of (VII) is then subjected to saponification by means of aqueous NaOH in THF/MeOH, and the resulting carboxylic acid is coupled to diaminopropionate derivative (VIII) in DMF by means of EDC, HOBt and N-methylmorpholine (NMM) to furnish amide (IX). Hydrolysis of the t-butyl ester group of (IX) by treatment with TFA in CH2Cl2 affords carboxylic acid (X), which is finally hydrogenated over Pd/C in dioxane/H2O to give the target compound.
【1】
Ajito, K.; Katano, K.; Kubota, D.; Ishikawa, M.; Murakami, S.; Hachisu, M.; Yamamoto, M. (Meiji Seika Kaisha, Ltd.); Aminopiperidine derivs. as integrin alphavbeta3 antagonists. EP 1074543; WO 9952872 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(II) |
45450 |
methyl 3,4-difluorobenzoate
|
369-25-5 |
C8H6F2O2 |
详情 | 详情
|
(III) |
45451 |
methyl 3-fluoro-4-(4-hydroxy-1-piperidinyl)benzoate
|
107-82-4 |
C13H16FNO3 |
详情 | 详情
|
(IV) |
45452 |
methyl 4-(4-azido-1-piperidinyl)-3-fluorobenzoate
|
|
C13H15FN4O2 |
详情 |
详情
|
(V) |
45453 |
methyl 4-(4-amino-1-piperidinyl)-3-fluorobenzoate
|
|
C13H17FN2O2 |
详情 |
详情
|
(VI) |
45454 |
2-bromopyrimidine
|
4595-60-2 |
C4H3BrN2 |
详情 | 详情
|
(VII) |
45455 |
methyl 3-fluoro-4-[4-(2-pyrimidinylamino)-1-piperidinyl]benzoate
|
|
C17H19FN4O2 |
详情 |
详情
|
(VIII) |
31423 |
tert-butyl (2S)-3-amino-2-[(phenylsulfonyl)amino]propanoate
|
|
C13H20N2O4S |
详情 |
详情
|
(IX) |
45456 |
tert-butyl (2S)-3-([3-fluoro-4-[4-(2-pyrimidinylamino)-1-piperidinyl]benzoyl]amino)-2-[(phenylsulfonyl)amino]propanoate
|
|
C29H35FN6O5S |
详情 |
详情
|
(X) |
45457 |
(2S)-3-([3-fluoro-4-[4-(2-pyrimidinylamino)-1-piperidinyl]benzoyl]amino)-2-[(phenylsulfonyl)amino]propionic acid
|
|
C25H27FN6O5S |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(I) 4-Hydroxypiperidine (I) was protected as the N-Boc derivative (II), which was then condensed with 1,2-difluoro-4-nitrobenzene (III) in the presence of potassium tert-butoxide, yielding ether (IV). Reduction of the nitro group of (IV) by transfer hydrogenation, followed by treatment of the resulting aniline (V) with benzyl chloroformate, afforded carbamate (VI). After deprotonation of the carbamate group of (VI) with n-butyllithium, reaction with (R)-glycidyl butyrate (VII) generated the chiral oxazolidinone (VIII). Conversion of (VIII) to mesylate (IX) and subsequent displacement with NaN3 provided azide (X). This was reduced to the corresponding amine, which was acetylated with Ac2O to furnish amide (XI). Cleavage of the Boc protecting group of (XI) with trifluoroacetic acid gave piperidine (XII). This was finally acylated with benzyloxyacetyl chloride (XIII) to provide the title amide.
【2】
Boggs, C.M.; et al.; Novel piperidinyloxy-oxazolidinone antimicrobial agents: Effects of position, fluorine substitution, and ring-size on in vitro antimicrobial activity. 220th ACS Natl Meet (Aug 20 2000, Washington DC) 2000, Abst MEDI 98.
|
【3】
Boggs, C.; Nelson, E.; Weidner-Wells, M.; Hlasta, D. (Ortho-McNeil Pharmaceutical, Inc.); Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials. WO 0146164 .
|
【1】
Hilliard, J.J.; Montenegro, D.A.; Nelson, E.A.; Goldschmidt, R.M.; Boggs, C.M.; Weidner-Wells, M.A.; Wira, E.; Hlasta, D.J.; Melton, J.; Foleno, B.D.; Bush, K.; Piperidinyloxy substituted oxazolidinones as antibacterial agents. Diversification of the N-substituent. 40th Intersci Conf Antimicrob Agents Chemother (Sept 17 2000, Toronto) 2000, Abst F-1828. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(II) |
18625 |
tert-butyl 4-hydroxy-1-piperidinecarboxylate
|
|
C10H19NO3 |
详情 |
详情
|
(III) |
17013 |
1,2-difluoro-4-nitrobenzene; 3,4-Difluoronitrobenzene
|
369-34-6 |
C6H3F2NO2 |
详情 | 详情
|
(IV) |
45645 |
tert-butyl 4-(2-fluoro-4-nitrophenoxy)-1-piperidinecarboxylate
|
|
C16H21FN2O5 |
详情 |
详情
|
(V) |
45646 |
tert-butyl 4-(4-amino-2-fluorophenoxy)-1-piperidinecarboxylate
|
654-01-3 |
C16H23FN2O3 |
详情 | 详情
|
(VI) |
45647 |
tert-butyl 4-(4-[[(benzyloxy)carbonyl]amino]-2-fluorophenoxy)-1-piperidinecarboxylate
|
|
C24H29FN2O5 |
详情 |
详情
|
(VII) |
18385 |
(2R)oxiranylmethyl butyrate;(R)-glycidyl butyrate |
60456-26-0 |
C7H12O3 |
详情 | 详情
|
(VIII) |
45648 |
tert-butyl 4-[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenoxy]-1-piperidinecarboxylate
|
|
C20H27FN2O6 |
详情 |
详情
|
(IX) |
45649 |
tert-butyl 4-[2-fluoro-4-((5R)-5-[[(methylsulfonyl)oxy]methyl]-2-oxo-1,3-oxazolidin-3-yl)phenoxy]-1-piperidinecarboxylate
|
22888-70-6 |
C21H29FN2O8S |
详情 | 详情
|
(X) |
45650 |
tert-butyl 4-[4-[(5R)-5-(azidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenoxy]-1-piperidinecarboxylate
|
|
C20H26FN5O5 |
详情 |
详情
|
(XI) |
45651 |
tert-butyl 4-(4-[(5S)-5-[(acetamido)methyl]-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenoxy)-1-piperidinecarboxylate
|
|
C22H30FN3O6 |
详情 |
详情
|
(XII) |
45652 |
N-([(5S)-3-[3-fluoro-4-(4-piperidinyloxy)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl)acetamide
|
2642-63-9 |
C17H22FN3O4 |
详情 | 详情
|
(XIII) |
10493 |
2-(Benzyloxy)acetyl chloride; Benzyloxyacetyl chloride
|
19810-31-2 |
C9H9ClO2 |
详情 | 详情
|
合成路线20
该中间体在本合成路线中的序号:
(I) 4-Hydroxypiperidine (I) was protected as the N-Boc derivative (II), which was then condensed with 1,2-difluoro-4-nitrobenzene (III) in the presence of potassium tert-butoxide, yielding ether (IV). Reduction of the nitro group of (IV) by transfer hydrogenation, followed by treatment of the resulting aniline (V) with benzyl chloroformate, afforded carbamate (VI). After deprotonation of the carbamate group of (VI) with n-butyllithium, reaction with (R)-glycidyl butyrate (VII) generated the chiral oxazolidinone (VIII). Conversion of (VIII) to mesylate (IX) and subsequent displacement with NaN3 provided azide (X). This was reduced to the corresponding amine, which was acetylated with Ac2O to furnish amide (XI). Cleavage of the Boc protecting group of (XI) with trifluoroacetic acid, followed by acylation of the resulting piperidine with benzyloxyacetyl chloride, provided amide (XII). Finally, hydrogenolysis of the O-benzyl group of (XII) by transfer hydrogenation in the presence of ammonium formate and Pd/C yielded the title hydroxyacetamide.
【1】
Weidner-Wells, M.A.; et al.; Novel piperidinyloxy oxazolidinone antibacterial agents. Diversification of the N-substituent. Bioorg Med Chem 2002, 10, 7, 2345.
|
【3】
Boggs, C.M.; et al.; Novel piperidinyloxy-oxazolidinone antimicrobial agents: Effects of position, fluorine substitution, and ring-size on in vitro antimicrobial activity. 220th ACS Natl Meet (Aug 20 2000, Washington DC) 2000, Abst MEDI 98.
|
【4】
Boggs, C.; Nelson, E.; Weidner-Wells, M.; Hlasta, D. (Ortho-McNeil Pharmaceutical, Inc.); Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials. WO 0146164 .
|
【2】
Hilliard, J.J.; Montenegro, D.A.; Nelson, E.A.; Goldschmidt, R.M.; Boggs, C.M.; Weidner-Wells, M.A.; Wira, E.; Hlasta, D.J.; Melton, J.; Foleno, B.D.; Bush, K.; Piperidinyloxy substituted oxazolidinones as antibacterial agents. Diversification of the N-substituent. 40th Intersci Conf Antimicrob Agents Chemother (Sept 17 2000, Toronto) 2000, Abst F-1828. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12076 |
4-Piperidinol; 4-Hydroxypiperidine
|
5382-16-1 |
C5H11NO |
详情 | 详情
|
(II) |
18625 |
tert-butyl 4-hydroxy-1-piperidinecarboxylate
|
|
C10H19NO3 |
详情 |
详情
|
(III) |
17013 |
1,2-difluoro-4-nitrobenzene; 3,4-Difluoronitrobenzene
|
369-34-6 |
C6H3F2NO2 |
详情 | 详情
|
(IV) |
45645 |
tert-butyl 4-(2-fluoro-4-nitrophenoxy)-1-piperidinecarboxylate
|
|
C16H21FN2O5 |
详情 |
详情
|
(V) |
45646 |
tert-butyl 4-(4-amino-2-fluorophenoxy)-1-piperidinecarboxylate
|
654-01-3 |
C16H23FN2O3 |
详情 | 详情
|
(VI) |
45647 |
tert-butyl 4-(4-[[(benzyloxy)carbonyl]amino]-2-fluorophenoxy)-1-piperidinecarboxylate
|
|
C24H29FN2O5 |
详情 |
详情
|
(VII) |
18385 |
(2R)oxiranylmethyl butyrate;(R)-glycidyl butyrate |
60456-26-0 |
C7H12O3 |
详情 | 详情
|
(VIII) |
45648 |
tert-butyl 4-[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenoxy]-1-piperidinecarboxylate
|
|
C20H27FN2O6 |
详情 |
详情
|
(IX) |
45649 |
tert-butyl 4-[2-fluoro-4-((5R)-5-[[(methylsulfonyl)oxy]methyl]-2-oxo-1,3-oxazolidin-3-yl)phenoxy]-1-piperidinecarboxylate
|
22888-70-6 |
C21H29FN2O8S |
详情 | 详情
|
(X) |
45650 |
tert-butyl 4-[4-[(5R)-5-(azidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenoxy]-1-piperidinecarboxylate
|
|
C20H26FN5O5 |
详情 |
详情
|
(XI) |
45651 |
tert-butyl 4-(4-[(5S)-5-[(acetamido)methyl]-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenoxy)-1-piperidinecarboxylate
|
|
C22H30FN3O6 |
详情 |
详情
|
(XII) |
45653 |
benzyl 4-(4-[(5S)-5-[(acetamido)methyl]-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenoxy)-1-piperidinecarboxylate
|
|
C25H28FN3O6 |
详情 |
详情
|